Global Subcutaneous Drug Delivery Devices Market by Product (Pen Injectors, Prefilled Syringes, Wearable Injectors) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global subcutaneous drug delivery devices market was valued at USD 21.22 billion in 2019. It is projected to grow at 10.4% compound annual growth rate (CAGR), between 2020 and 2027. The demand for subcutaneous self administered drug delivery devices has increased due to the availability of minimally invasive drugs delivery devices, increasing prevalence of diabetes and Cardiovascular Diseases and an increase in biologic drug development. The International Diabetes Federation (IDF) predicts that the global diabetic population will grow by 48.0% between 2017-2045. IDF also stated that the incidence of diabetes will increase dramatically in low- and middle-income countries as compared with developed countries. According to the World Heart Federation type 2 diabetics are more likely to develop CVD than non-diabetics.

Subcutaneous drug delivery devices are becoming more popular. This has led to a reduction in dosage errors as well as the prevention of needlestick injury. Patients who have devices that allow for easy drug administration are more likely to adhere to treatment. The Annals of Internal Medicine found that nearly half of chronic patients who have been prescribed medication for their conditions quit taking it within one year. The study found that treatment failure can lead to 125,000 deaths and 10.0% hospitalizations. This is in addition to the US healthcare system spending USD 17 billion annually. Subcutaneous drug delivery that is painless can have a direct impact on the management of many chronic medical conditions.

Because they do not cause needlestick injuries, needle-free injectors are a viable alternative to conventional drug delivery platforms. They also reduce treatment costs. The Occupational Safety and Healthcare Administration reports that 384,000 needlestick-related injuries and other sharps-related injuries are reported annually to healthcare workers in the U.S. PATH Vaccine Resource Library conducted a survey and found that needlestick injuries are responsible for 21.0 million hepatitis A, 260,000 HIV and 2,000,000 hepatitis C cases. This leads to 1.3 million premature deaths worldwide.

Product Insights

The pen injections segment dominated subcutaneous drug delivery devices market and accounted for 38.0% of the total revenue. Positive growth indicators include increased product approvals, easier product design, greater affordability, and better social acceptance. To gain an advantage in the subcutaneous drug delivery device market, the developers are actively working to address the weaknesses of these delivery devices. Sanofi S.A., for example, announced in March 2018 that the maximum unit injection pen - Toujeo Max SoloStar - was approved by the U.S. FDA. The device can hold 900 units/mL. This device will reduce injections and lower medical expenditure.

Over the forecast period, the subcutaneous drug delivery device market is expected to grow at the fastest rate. Physicians increasingly prescribe wearable injectors (also known as patch pumps or Bolus Injectors) to administer large volumes of biologic drugs. The physicians can use these digitally powered subcutaneous drug delivery systems to increase the quality of their care and reduce healthcare costs. This will also improve patient outcomes.

Distribution Channel Insights

In 2019, the market for subcutaneous drugs delivery devices saw the largest share of revenue at 44.9%, which was the largest segment. This could be due to patient awareness and self-management, as well as a greater focus on positive outcomes. Manufacturers are also launching programs that provide uninterrupted insulin access for patients who don't have insurance, helping to alleviate the COVID crisis.

Due to the discounts provided by developers for subcutaneous drug delivery devices, the online pharmacy segment will experience the highest growth. Express Scripts and Eli Lilly partnered in 2017 to offer discounts on their products for web and mobile platforms. This allows patients to have greater access to vital medicines in developing and underdeveloped countries due to the affordability of these medications.

Regional Insights

North America was the dominant market for subcutaneous drug delivery systems in 2019, accounting for 44.1% of the total revenue. It is expected that the region will continue to dominate the market for subcutaneous drug delivery devices over the forecast period. The region's dominance can be attributed to its developed healthcare infrastructure, presence of major players in the area, and ongoing strategic initiatives to increase their market share. Portal Instruments, Inc. and LEO Pharma collaborated in December 2019 to develop a subcutaneous drug delivery device that is needle-free. The market for subcutaneous drug delivery systems is growing due to increasing numbers of chronic diseases such as multiple sclerosis and diabetes. The National Multiple Sclerosis Society estimates that 1.0 million Americans were living with multiple sclerosis in 2017.

The subcutaneous drug delivery market in Asia Pacific is expected to expand at a profitable rate during the forecast period. This is due to an increase in diabetes patients. The International Diabetes Federation (IDF) states that Asia accounts for 60.0% of global diabetes patients. IDF also stated that India will have the highest rate of growth in diabetics in 2025 with 72.0 millions cases in 2017.

Market Share Insights & Key Companies

Subcutaneous drug delivery devices are highly fragmented. Large and small-scale vendors offer a wide range of devices for various diseases. To maintain their market share, market players use a variety of strategies to keep their market share. These include product launch, strategic acquisitions and product innovation. Insulet Corporation was approved by the U.S. FDA in June 2018 for its Omnipod DASH insulin management platform. These digital platforms enable better patient outcomes in diabetic patients. The market leader in subcutaneous drug delivery devices is:

• Gerresheimer AG

• Medtronic Plc

• Ypsomed AG

• Elcam Medical Group

• Novo Nordisk

• Insulet Corporation

• Becton, Dickinson and Company

• West Pharmaceutical Services, Inc.

• PharmaJet

• Unilife Corporation

• Inolife Sciences

Up Market Research published a new report titled “Subcutaneous Drug Delivery Devices Market research report which is segmented by Product (Pen Injectors, Prefilled Syringes, Wearable Injectors), By Players/Companies West Pharmaceutical Services Inc, Inolife Sciences       , PharmaJet, Becton Dickinson and Company, Insulet Corporation, Novo Nordisk, Unilife Corporation, Ypsomed AG, Gerresheimer AG, Elcam Medical Group, Medtronic Plc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Subcutaneous Drug Delivery Devices Market Report Segments:

The market is segmented by Product (Pen Injectors, Prefilled Syringes, Wearable Injectors).

Subcutaneous Drug Delivery Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Subcutaneous Drug Delivery Devices Market

Overview of the regional outlook of the Subcutaneous Drug Delivery Devices Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Subcutaneous Drug Delivery Devices Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Subcutaneous Drug Delivery Devices Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Pen Injectors

                2. Prefilled Syringes

                3. Wearable Injectors

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Subcutaneous Drug Delivery Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Subcutaneous Drug Delivery Devices Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.